(Q43717548)

26 November 2017

Acceleration of HIV dementia with methamphetamine and cocaine (English)

1 reference

26 November 2017

0 references

0 references

A Nath

1

1 reference

26 November 2017

W F Maragos

2

1 reference

26 November 2017

M J Avison

3

1 reference

26 November 2017

F A Schmitt

4

1 reference

26 November 2017

J R Berger

5

1 reference

26 November 2017

1 February 2001

1 reference

26 November 2017

Journal of NeuroVirology

1 reference

26 November 2017

7

1 reference

26 November 2017

1

1 reference

26 November 2017

66-71

1 reference

https://scigraph.springernature.com/pub.10.1080/135502801300069737

26 November 2017

0 references

cites work

Variable progression of HIV-associated dementia

1 reference

12 December 2020

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement

1 reference

12 December 2020

HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

1 reference

12 December 2020

HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia

1 reference

12 December 2020

Effects of HIV seropositivity and drug abuse on cognitive function

1 reference

12 December 2020

Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity

1 reference

12 December 2020

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

Exogenous tat protein activates central nervous system-derived endothelial cells

1 reference

12 December 2020

Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine

1 reference

12 December 2020

Cerebrospinal fluid dopamine in HIV-1 infection

1 reference

12 December 2020

Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis?

1 reference

12 December 2020

HIV infection and cognition in intravenous drug users: long-term follow-up.

1 reference

12 December 2020

HIV Dementia Scale: a rapid screening test.

1 reference

12 December 2020

Cerebrovascular changes in the basal ganglia with HIV dementia

1 reference

12 December 2020

Cerebrospinal fluid catecholamine metabolites in HIV-infected patients

1 reference

12 December 2020

Phenytoin and dyskinesias: a report of two cases and review of the literature

1 reference

12 December 2020

Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences

1 reference

12 December 2020

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

1 reference

12 December 2020

The AIDS dementia complex: II. Neuropathology.

1 reference

12 December 2020

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon.

1 reference

12 December 2020

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.

1 reference

12 December 2020

Evidence that Par-4 participates in the pathogenesis of HIV encephalitis

1 reference

12 December 2020

Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus

1 reference

12 December 2020

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

12 December 2020

Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men.

1 reference

12 December 2020

Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms

1 reference

12 December 2020

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

1 reference

12 December 2020

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

1 reference

12 December 2020

The AIDS dementia complex

1 reference

12 December 2020

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

12 December 2020

Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

1 reference

12 December 2020

Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.

1 reference

12 December 2020

Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS.

1 reference

12 December 2020

Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.

1 reference

12 December 2020

HIV dementia and the basal ganglia

1 reference

12 December 2020

10.1080/135502801300069737

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference